Blog - Page 5514 of 5554

FridayJul 21, 2006 10:57 am

StockGuru Profile News: Elgrande International, Inc. (OTCBB: EGDI)

StockGuru Profile Elgrande International, Inc. (OTCBB: EGDI) Elgrande to Begin Production of Ginger Kelly Line in China Due to Difficulties in Delivery of Love Plates Product VANCOUVER, BC— Elgrande International (OTCBB: EGDI) announced today that they are accelerating strategic plans to manufacture the Ginger Kelly line of artist designed glassware in China. Steadily increasing sales of the Ginger Kelly line have made production in China, which provides increased production capabilities and higher profit margins, very attractive. Sales of this popular line of glassware have grown significantly. The Company’s inability to meet demand for the glassware has necessitated the acceleration of…

ThursdayJul 20, 2006 11:06 am

StockGuru News: Bad Toys Holdings, Inc. Renews 3 Year Contract for Approximate $2.5 Million Gross Revenue in Linn County, Kansas

Bad Toys Holdings, Inc. Renews 3 Year Contract for Approximate $2.5 Million Gross Revenue in Linn County, Kansas Bad Toys Holdings, Inc. (OTCBB: BTYH) KINGSPORT, TN–(MARKET WIRE)–Jul 20, 2006 — Bad Toys Holdings, Inc. (OTC BB:BTYH.OB - News) announced today that its Southland Health Services division has been awarded its renewal of a 3 year contract to be the sole provider in Linn County, Kansas. This agreement included both emergency and non-emergency ambulance service. The Company will continue to be the sole provider for this county for the next 3 years with an option to renew. The Company expects gross…

ThursdayJul 20, 2006 11:05 am

StockGuru Blog: Immune Response was Pioneered by a Medical Legend: Dr. Jonas Salk, Developer of the First Polio Vaccine

IMNR - The Immune Response CorporationThe Immune Response Corp. Uses the Immune System to Treat Targeted Diseases: Multiple Sclerosis (MS) and HIV/AIDS The Immune Response Corporation was founded in 1986 by Dr. Jonas Salk, the developer of the first polio vaccine. Therapies in development at IMNR are based on using the body’s immune system to slow or stop the progression of the diseases. Two products in Phase II clinical trials are NeuroVax, targeting MS, and IR103 that targets HIV/AIDS. These therapies could be used alone or in combination with other drugs, enabling the Company to realize multi-billion dollar sales. Other…

ThursdayJul 20, 2006 10:57 am

StockGuru Trade Alert: Cavico Corporation (OTC: CVCP) Up From $2.10 to $2.73 Since Coverage Started Just This Monday

Cavico Corporation (OTC: CVCP) StockGuru Trade Alert: Cavico Corporation (OTC: CVCP) Up From $2.10 to $2.73 Since Coverage Started Just This Monday Last Friday’s Close: $2.10 Monday’s Open: $2.73 That’s 30% Volume: Prior Ten Day Average: 5,415 Shares Average This Week: 33,893 Shares That’s more than a 600% increase in volume View the StockGuru Profile for Cavico Corporation: http://www.stockguru.com/profiles/cvcp/ We Invite you to Visit the All New StockGuru Blog! Here you will find updates on all our covered companies, including Profiled Companies and StockGuru Picks. Click HERE to visit the Blog, or go to: http://stockguru.com/blog/ StockGuru.com is owned and operated…

ThursdayJul 20, 2006 9:47 am

StockGuru News: Response Biomedical Corp, Clearly Canadian Beverage Corporation, and Franklin Mining

Response Biomedical Corp. (OTCBB: RPBIF) Response Biomedical’s BNP Test For Congestive Heart Failure Launched In Japan Shionogi Purchasing 200 RAMP Systems for Launch VANCOUVER, July 20 /CNW/ - Response Biomedical Corporation (TSX-V: RBM, OTCBB: RPBIF) announced today it has shipped 100 RAMP Readers to Shionogi & Co., Ltd. for commercial sale in Japan, with the balance of the order to be shipped this summer. As part of this initial purchase order Response Biomedical has also shipped a quantity of BNP tests to be used on these systems. BNP (B-type natriuretic peptide) is a proprietary cardiac marker test to assist in…

ThursdayJul 20, 2006 9:47 am

StockGuru Blog: Avatar Systems, Inc. Selected for $330,000 Contract

AVSY — Avatar Systems, Inc. Neumin Production Company of Point Comfort, Texas, has selected Avatar’s oil and gas enterprise software solutions and document imaging product to enhance and upgrade its systems. Chuck Shreve, President and Chief Executive Officer of Avatar stated, “Neumin Production is a long-time customer for our company and should generate approximately $330,000 in additional revenue in the first year. Neumin is an example not only of the potential for our products but the type of high quality exploration and production company that we target.” Avatar Systems, Inc. is based in Frisco, Texas. The company provides enterprise resource…

WednesdayJul 19, 2006 9:47 am

StockGuru Blog: Avatatar Systems, Inc. Receives Titans Fast Fifty Award

AVSY — Avatar Systems, Inc. Avatar Systems, Inc. (OTC Bulletin Board: AVSY) has been selected by the Metroplex Technology Business Council (MTBC), the region’s most prominent organization supporting technology, for the Titan Fast 50 Award. The Titan Fast 50 recognizes the fifty fastest growing technology companies in the Dallas-Fort Worth area. The award is based on percentage revenue growth over five years (2000 to 2004) as well as percentage revenue growth over one year (2003-2004). The formal awards ceremony and dinner will be held on Friday, August 19th at the Charles W. Eisemann Center in Richardson, Texas. Chuck Shreve, President…

WednesdayJul 19, 2006 9:43 am

StockGuru Blog: The Immune Response Corporation Advancing the Knowledge in AIDS/HIV and MS Research

IMNR - The Immune Response CorporationThe Immune Response Corporation is a development stage biotechnology company with two products in Phase II clinical trials, one that targets multiple sclerosis (MS) and another that targets HIV/AIDS. These drugs act by stimulating the body’s immune system to slow or stop disease progression through mechanisms of action that differ from existing drugs.These diseases have large patient populations and substantial room for improvement over current therapies. If successful, these drugs could be used alone or in combination with other drugs, giving multibillion dollar sales potential. The Company has made significant changes over the past year,…

WednesdayJul 19, 2006 9:42 am

StockGuru Blog: The Immune Response Corporation’s New CEO Leader in Global HIV/AIDS MD at the Helm

IMNR - The Immune Response CorporationJoseph F. O’Neill, M.D., M.S., M.P.H. is the president and CEO of The Immune Response Corporation. Dr. ONeill’s experience in establishing and administering public health policies gives him insight into diseases, their treatments, and the needs of patient populations as well as the doctors who treat them. Dr. O’Neill has spent the past five years in AIDS related research. Before joining the Company he served as Deputy U.S. Global AIDS Coordinator and Chief Medical Officer for the Office of the Global AIDS Coordination at the U.S. Department of State (from August 2003 to August 2005).…

WednesdayJul 19, 2006 9:38 am

StockGuru Trade Alert: StatSure Diagnostic Systems, Inc. (OTCBB: SSUR) Up Intraday More than 23.5% to $1.05 from Yesterday’s Close of $0.85

StockGuru Trade Alert: StatSure Diagnostic Systems, Inc. (OTCBB: SSUR) Up Intraday More than 23.5% to $1.05 from Yesterday’s Close of $0.85 StatSure Diagnostic Systems, Inc. (OTCBB: SSUR) View the StockGuru Profile for StatSure Diagnostic Systems, Inc.: http://www.stockguru.com/profiles/ssur/ We Invite you to Visit the All New StockGuru Blog! Here you will find updates on all our covered companies, including Profiled Companies and StockGuru Picks. Click HERE to visit the Blog, or go to: http://stockguru.com/blog/ StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com. Disclosure: Pentony Enterprises…

Site Search

Company Search